Furthermore, the industry is moving toward . Instead of just testing the final product, manufacturers are using real-time bioburden monitoring and endotoxin removal chromatography to eliminate LER risk at the source.

: Modifying formulation or manufacturing parameters to reduce LER risk, though such changes must be balanced against product stability and efficacy requirements.

: Studies should simulate actual product storage conditions—typically refrigerated (2–8°C) and/or room temperature.

If LER occurs, a product could be contaminated with active, toxic endotoxins, yet pass the mandatory LAL bacterial endotoxin test (BET). 2. The Scope and Purpose of PDA Technical Report 82

Offering guidance on how to properly design hold-time studies.

) to displace the surfactant and reaggregate the lipopolysaccharides.

pda technical report 82